Chromogranin A anticorps (C-Term)
Aperçu rapide pour Chromogranin A anticorps (C-Term) (ABIN7598846)
Antigène
Voir toutes Chromogranin A (CHGA) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 427-453, C-Term
-
Fonction
- Anti-Chromogranin A
-
Specificité
- Chromogranin A
-
Immunogène
- Peptide derived from C-terminal sequence of human chromogranin A. Antibody recognizes the epitope between Arg427 - Ala453.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- +2 °C to +8 °C
-
-
- Chromogranin A (CHGA)
-
Autre désignation
- Chromogranin A
-
Sujet
- Chromogranin A is a major member of the family of acidic secretory glycoproteins, expressed in all endocrine and neuroendocrine cells. Chromogranin A expression has been detected in number of neuroendocrine tumors, including phaeochromocytomas, medullary thyroid carcinomas, pituitary adenomas and Merkel cell tumors.
-
UniProt
- P10645
-
Pathways
- Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-